Table 2.
Patient characteristics.
| Characteristics | CADa (N=19) | HFrEFb (N=19) | |||
| Age (years), mean (SD) | 61.4 (6.9) | 65.1 (6.6) | |||
| Gender, n (%) | |||||
|
|
Male | 14 (74) | 17 (89) | ||
|
|
Female | 5 (26) | 2 (11) | ||
| Height (cm), mean (SD) | 176 (6.8) | 177 (5.4) | |||
| Weight (kg), mean (SD) | 84.3 (12.1) | 86.7 (13.7) | |||
| BMIc (kg/m2), mean (SD) | 27.1 (3.1) | 27.7 (4.2) | |||
| LVEFd (%), mean (SD) | 60.5 (4.5) | 31.8 (7.6) | |||
| NYHAe classification I/II/III/Unknown, n (%) | —f | 6(32)/11(58)/1(5)/1(5) | |||
| Heart failure etiology, n (%) | |||||
|
|
Ischemic | — | 11 (58) | ||
|
|
Nonischemic | — | 8 (42) | ||
| Medication, n (%) | |||||
|
|
Beta-blocker | 12 (63) | 15 (79) | ||
|
|
Calcium channel blocker (non-DHPg) | 2 (11) | 0 (0) | ||
|
|
Amiodarone | 0 (0) | 4 (21) | ||
|
|
Ivabradine | 0 (0) | 1 (5) | ||
aCAD: coronary artery disease.
bHFrEF: heart failure with reduced ejection fraction.
cBMI: body mass index.
dLVEF: left ventricular ejection fraction.
eNYHA: New York Heart Association.
fNot applicable.
gDHP: dihydropyridine.